Log in to search using one of your social media accounts:

 

Intra-Articular Corticosteroid Injections in Knee OA Intra-Articular Corticosteroid Injections in Knee OA
Intra-articular corticosteroid injections are a non-surgical treatment option for knee OA, but certain patient factors may impact efficacy.Journal of the American Academy of Orthopaedic Surgeons (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 24, 2017 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

After FDA nod, Flexion launches osteoarthritis injection
Flexion Therapeutics (NSDQ:FLXN) today launched its Zilretta therapy designed to help patients manage pain associated with osteoarthritis of the knee. The Burlington, Mass.-based company’s extended-release intra-articular injection combines a commonly administered, short-acting corticosteroid with a polylactic-co-glycolic acid matrix using Flexion’s microsphere technology. Get the full story at our sister site, Drug Delivery Business News. The post After FDA nod, Flexion launches osteoarthritis injection appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Orthopedics Pain Management Pharmaceuticals Wall Street Beat Flexion Therapeutics Source Type: news

Corticosteroids do not increase risk of bone fractures
According to a study, published inJAMA Pediatrics, children on daily inhalable corticosteroids do not have an increased risk of bone fractures.Medscape (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 16, 2017 Category: Endocrinology Source Type: news

Inhaled Corticosteroids Not Linked to Fracture in Children
Systemic, but not inhaled, corticosteroids associated with higher fracture risk in pediatric asthma patients (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 14, 2017 Category: Respiratory Medicine Tags: Family Medicine, Nursing, Orthopedics, ENT, Pediatrics, Pharmacy, Pulmonology, Radiology, Allergy, Emergency Medicine, Journal, Source Type: news

Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate ® (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Positive Opinion Based on Five Studies Demonstrating Nplate Reduces Rates of Bleeding in Children With Rare Blood Disorder THOUSAND OAKS, Calif., Nov. 10, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for Nplate® (romiplostim) to include the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) for patients one year of age and older who are refractory to other treatments (e.g., corticosteroids, immunoglobulins). T...
Source: Amgen News Release - November 10, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Topical corticosteroids reduce retinoid irritation, study shows
Transient topical corticosteroids could take edge off severe irritation from topical retinoid acne treatment without decreasing efficacy. (Source: Dermatology Times)
Source: Dermatology Times - November 1, 2017 Category: Dermatology Source Type: news

Corticosteroids for Treatment of Sore Throat Corticosteroids for Treatment of Sore Throat
Do the benefits outweigh the potential risks of using corticosteroids as an adjunct treatment for acute sore throat?The BMJ (formerly known as the British Medical Journal) (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 13, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Boehringer Ingelheim, Anthem partner for largest real-world COPD trial
As part of a research collaboration launched in 2014, Boehringer Ingelheim and Anthem have partnered to study people with chronic obstructive pulmonary disease in real-world settings to assess how commonly-prescribed drugs may reduce the occurrence of COPD exacerbations. The team, which also includes Anthem’s outcomes research subsidiary HealthCore, plans to investigate whether adding an inhaled corticosteroid to a LAMA-LABA combination provides a meaningful benefit – a question under debate in the respiratory space. Get the full story at our sister site, Drug Delivery Business News. The post Boehring...
Source: Mass Device - October 12, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat Anthem Inc. Boehringer Ingelheim Pharmaceuticals Source Type: news

Corticosteroids vs. NSAIDs
Title: Corticosteroids vs. NSAIDsCategory: MedicationsCreated: 10/12/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 12, 2017 Category: Drugs & Pharmacology Source Type: news

First UK guideline published for lupus management in adults
The smallest effective dose of corticosteroids should be used to treat adult patients with lupus, according to the first ever UK guideline specifically for the management of the condition. (Source: Nursing Times)
Source: Nursing Times - October 9, 2017 Category: Nursing Source Type: news

How Common Is Hereditary Angioedema?
Discussion Angioedema is edema that is non-pitting, self-limited occurring in non-dependent areas usually in an asymmetric distribution usually on the lips, face, hands, feet, genitals and also in the bowel. It usually develops over minutes to hours (often 1-2 hours) with resolution usually within 24-48 hours. Angioedema often occurs with urticaria but 20% of patients may have isolated angioedema. Acute allergic angioedema is often caused by drugs (including antibiotics and non-steroidal anti-inflammatory drugs), foods, infections, insects, various organic substances (i.e. latex, preservatives, formaldehyde, etc.), and oth...
Source: PediatricEducation.org - October 9, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

FDA OKs First Extended-Release Corticosteroid Shot for Knee OA FDA OKs First Extended-Release Corticosteroid Shot for Knee OA
Triamcinolone acetonide extended-release injectable suspension (Zilretta) is a nonopioid option that provides knee OA pain relief over 12 weeks.FDA Approvals (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - October 6, 2017 Category: Universities & Medical Training Tags: Rheumatology News Alert Source Type: news

Vitamin D may prevent asthma worsening for some
Conclusion This review gathers the available trial evidence to address the specific question of whether giving people with asthma vitamin D supplements could have an effect on how many asthma exacerbations they have. The review has many strengths. It only included double-blind trials, where participants and assessors didn't know if people were taking vitamin D or a placebo. Researchers also made careful attempts to gather all relevant data and information on confounding factors, and all but one trial had a low risk of bias. But there are some limitations to bear in mind: With the relatively small number of trials and par...
Source: NHS News Feed - October 5, 2017 Category: Consumer Health News Tags: Heart/lungs Source Type: news

LAMA Plus LABA Tied to Fewer Exacerbations in Stable COPD
Also might result in greater improvement in FEV1 than LABA plus corticosteroids (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 4, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Internal Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Hip pain in young athletes: Q & A with a sports medicine specialist
When your child plays a sport, it’s often hard to tell where everyday aches and pains end and a potentially serious injury begins. Bumps and bruises are anything but rare in contact sports, and muscle soreness can be a common complaint for any young athlete — especially given the rigor of youth athletics these days. So how do you know when your child’s hip pain is due to an actual injury? Dr. Mininder Kocher, orthopedic surgeon and Associate Director of the Sports Medicine Division at Boston Children’s Hospital, helps answer parents’ questions about hip pain in young athletes. What are s...
Source: Thrive, Children's Hospital Boston - October 3, 2017 Category: Pediatrics Authors: Connor Ertz Tags: Ask the Expert Child and Young Adult Hip Preservation Program Division of Sports Medicine Dr. Mininder Kocher FAI femoracetabular impingement hip dysplasia hip impingement labral tear Source Type: news

Xhance ™ (fluticasone propionate) for the Treatment of Nasal Polyps
Xhance ™ (fluticasone propionate / previously known as OPN-375), a synthetic trifluorinated corticosteroid, is indicated for the treatment of nasal polyps in patients aged 18 years or older. (Source: Drug Development Technology)
Source: Drug Development Technology - September 26, 2017 Category: Pharmaceuticals Source Type: news

Meta-Analysis: Corticosteroids Improve Pain Relief in Acute Sore Throat (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM A single dose of corticosteroids offers pain relief in patients with acute sore throat, according to a meta-analysis in The BMJ.Researchers … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 21, 2017 Category: Primary Care Source Type: news

Following regulatory win, GSK & Innoviva tout data for once-daily triple-med inhaler
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) notched a win this week after the FDA approved its once-daily, triple combination therapy for the treatment of chronic obstructive pulmonary disease. Last week, an EU agency recommended the inhaler’s approval. Now, the companies are touting results from a late-stage trial of Trelegy Ellipta, which is composed of an inhaled corticosteroid, a long-acting muscarinic antagonist and a long-acting beta agonist. Get the full story at our sister site, Drug Delivery Business News. The post Following regulatory win, GSK & Innoviva tout data f...
Source: Mass Device - September 20, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat GlaxoSmithKline plc Innoviva Source Type: news

Boston Scientific touts 3-year Alair follow-up study results
Boston Scientific (NYSE:BSX) today released 3-year follow-up cohort results from the post-FDA approved PAS2 clinical trial of its Alair system designed for bronchial thermoplasty to treat severe persistent asthma, touting reduced severe asthma attacks, hospitalizations and ER visits. Results from the trial were recently published in the European Respiratory Journal, the Marlborough, Mass.-based company said. The PAS2 trial is an open-label study which enrolled patients at 27 North American centers, with 95% of the recruited patients considered severe asthmatics. Boston Scientific said that data from the cohort co...
Source: Mass Device - September 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Respiratory Boston Scientific Source Type: news

GSK ’s triple-med COPD inhaler wins recommendation for approval in EU
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) said today that a European Medicines Agency panel recommended marketing authorization for the Trelegy Ellipta triple-combination inhaler for adults with COPD. The device uses fluticasone furoate, umeclidinium and vilanterol to help adults with COPD who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist. It’s also the first once-daily single inhaler triple therapy to win a positive opinion by the Committee for Medicinal Products for Human Use, the companies reported. Get the full story at our sister...
Source: Mass Device - September 15, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat GlaxoSmithKline plc Innoviva Source Type: news

Interventions for treating tuberculous pericarditis
(Liverpool School of Tropical Medicine) Researchers from South Africa and Canada have carried out a Cochrane review update to assess the safety and effectiveness of corticosteroids for treating tuberculous pericarditis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 14, 2017 Category: Infectious Diseases Source Type: news

Expensive drug driving up Medicare expenditures without evidence of greater efficacy
(Oregon State University) Medicare spent more than $1 billion over a five-year period on a high-priced drug that has not been proven more effective for a collection of inflammatory conditions than much less expensive corticosteroids. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 11, 2017 Category: International Medicine & Public Health Source Type: news

Oral Corticosteroids of No Benefit in Nonasthmatic Adults with Lower Respiratory Tract Infection (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH Oral corticosteroids offer no benefit to nonasthmatic adults with acute lower respiratory tract infection, according to a placebo-controlled trial in JAMA … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 23, 2017 Category: Primary Care Source Type: news

Oral Corticosteroids No Benefit for LRI in Non - Asthmatic Adults
No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Emergency Medicine, Nursing, ENT, Pharmacy, Pulmonology, Journal, Source Type: news

Corticosteroid injection may offer little advantage for Morton ’s neuroma patients treated with local anesthetic
According to a study published online in the journal Foot & Ankle International, corticosteroid injection plus local anesthetic may not be superior to local anesthetic alone in terms of pain and function for patients with Morton’s neuroma.  (Source: Orthogate - Latest News)
Source: Orthogate - Latest News - August 20, 2017 Category: Orthopaedics Tags: Featured Editors Choice News Source Type: news

Drug safety update: Corticosteroids: rare risk of central serous chorioretinopathy
The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a drug safety update ...... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - August 17, 2017 Category: Drugs & Pharmacology Source Type: news

Laser in the management of burn scars
Burn scars are associated with significant morbidity ranging from contractures, pruritus, and disfigurement to psychosocial impairment. Traditional therapies include silicone gel, compression garments, corticosteroid injections, massage therapy, and surgical procedures, however, newer and advanced therapies for the treatment of burn scars have been developed. Lasers, specifically ablative fractional lasers, show potential for the treatment of burn scars. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 8, 2017 Category: Consumer Health News Source Type: news

Oral Corticosteroids Tied to Serious Adverse Events in IgA Nephropathy (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Oral corticosteroids for patients with immunoglobulin A nephropathy are associated with increased risk for serious infections, a JAMA study finds.Some 260 … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 2, 2017 Category: Primary Care Source Type: news

Infection Concern Halts Kidney Disease Drug Trial
Doctors should weigh risks, benefits related to corticosteroid use, study suggests (Source: WebMD Health)
Source: WebMD Health - August 1, 2017 Category: Consumer Health News Source Type: news

Drug for Kidney Disease Tied to Infection Risk
Doctors should weigh risks, benefits related to corticosteroid use, study suggests Source: HealthDay Related MedlinePlus Pages: Kidney Diseases (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 1, 2017 Category: Consumer Health News Source Type: news

Methylprednisolone for Kidney Disease Tied to Infection Risk
TUESDAY, Aug. 1, 2017 -- A drug used for some cases of kidney disease can raise the risk of serious infections, researchers say. A clinical trial was stopped early when researchers discovered that patients on the drug -- a corticosteroid called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 1, 2017 Category: General Medicine Source Type: news

Fear Keeps Many Eczema Patients From Using Steroid Creams Fear Keeps Many Eczema Patients From Using Steroid Creams
Many people with eczema may avoid creams and ointments that can help ease symptoms like itching and inflammation because they ’ re afraid to try topical corticosteroids, a recent study suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 28, 2017 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

NICE backs biologic for treating condition that can cause blindness
A monoclonal antibody and a biodegradable corticosteroid implant have been approved for use by the NHS in England and Wales to treat an inflammatory eye condition that can lead to blindness. (Source: Nursing Times)
Source: Nursing Times - July 28, 2017 Category: Nursing Source Type: news

Fear keeps many eczema patients from using steroid creams
(Reuters Health) - Many people with eczema, a common skin disease, may avoid creams and ointments that can help ease symptoms like itching and inflammation because they ’re afraid to try topical corticosteroids, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - July 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Clearside Biomedical launches Phase II diabetic macular edema trial
Clearside Biomedical (NSDQ:CLSD) said today that it enrolled the first patient in a Phase II clinical trial of CLS-TA in patients with diabetic macular edema. The trial plans to evaluate Clearside’s suspension formulation of a corticosteroid, triamcinolone acetonide, as a suprachoroidal injection in combination with an intravitreal injection of Eylea, an anti-VEGF agent. Get the full story at our sister site, Drug Delivery Business News. The post Clearside Biomedical launches Phase II diabetic macular edema trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 12, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Diabetes Optical/Ophthalmic Pharmaceuticals Wall Street Beat Clearside Biomedical Source Type: news

​Ocular Therapeutix faces fraud allegations as FDA rejects eye drug
Bedford eye care biotech Ocular Therapeutix saw its share price plummet on Wednesday after the FDA rejected its lead drug for the second time. To make matters worse, the company and its top executives are now facing fraud allegations in federal court. Ocular (Nasdaq: OCUL) said after markets closed on Tuesday that the FDA had denied its application for Dextenza, a tiny insert that is placed in the eye and delivers a corticosteroid to treat pain following surgical procedures. Regulators cited manufacturing… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 12, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Better Vision-related QOL With Fluocinolone Acetonide Implant for Uveitis Better Vision-related QOL With Fluocinolone Acetonide Implant for Uveitis
Treatment of noninfectious uveitis with fluocinolone acetonide implants is associated with better vision-related quality of life, compared with systemic corticosteroid therapy, according to results from the MUST research group.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - July 5, 2017 Category: Opthalmology Tags: Ophthalmology News Source Type: news

School's in for asthma medication adherence
(Children's National Health System) Stephen J. Teach, M.D., M.P.H., and colleagues tried to reduce missed doses of daily medications, improve asthma control and tamp down on schoolchildren's asthma attacks by outsourcing morning delivery of inhaled corticosteroids to the school nurse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2017 Category: International Medicine & Public Health Source Type: news

Drug cocktail may help prevent sepsis shock, death
Researchers have found that a drug cocktail of vitamin C, corticosteroids and thiamine may help prevent progressive organ failure caused by sepsis. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 26, 2017 Category: Consumer Health News Source Type: news

Readily available drug cocktail may help prevent sepsis shock and death
(Elsevier) Even in advanced medical settings, sepsis is still very dangerous and accounts for over 400,000 deaths annually in the US alone. While new drugs are in development, a group of researchers has determined that a combination of intravenous vitamin C, corticosteroids (a steroid), and thiamine (vitamin B) may be effective in preventing progressive organ dysfunction and reducing the number of deaths from severe sepsis and septic shock. Their findings are published in the June issue of CHEST. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2017 Category: International Medicine & Public Health Source Type: news

Readily available drug cocktail can help prevent sepsis shock and death
(Elsevier) Even in advanced medical settings, sepsis is still very dangerous and accounts for over 400,000 deaths annually in the US alone. While new drugs are in development, a group of researchers has determined that a combination of intravenous vitamin C, corticosteroids (a steroid), and thiamine (vitamin B) may be effective in preventing progressive organ dysfunction and reducing the number of deaths from severe sepsis and septic shock. Their findings are published in the June issue of CHEST. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 26, 2017 Category: International Medicine & Public Health Source Type: news

Thinking Machines: From Magic to Normal
“Technology made large populations possible; large populations now make technology indispensable.”                – Joseph Krutch (Writer)Since the 19th century, we have undergone several stages of machine revolutions.The first stage was mechanisation. The advent of modern production methods eased and sped up manufacturing, massively increasing output and ushering in the Industrial Revolution.The late 60s brought the age of the working computer. In 1967, an IBM infomercial, ‘The Paperwork Explosion’, predicted a dystopi...
Source: EyeForPharma - June 22, 2017 Category: Pharmaceuticals Authors: Jacqui Sanders Source Type: news

Thinking Machines: From Magic to Normal
“Technology made large populations possible; large populations now make technology indispensable.”                – Joseph Krutch (Writer)Since the 19th century, we have undergone several stages of machine revolutions.The first stage was mechanisation. The advent of modern production methods eased and sped up manufacturing, massively increasing output and ushering in the Industrial Revolution.The late 60s brought the age of the working computer. In 1967, an IBM infomercial, ‘The Paperwork Explosion’, predicted a dystopi...
Source: EyeForPharma - June 22, 2017 Category: Pharmaceuticals Authors: Jacqui Sanders Source Type: news

Thinking Machines: From Magic to Normal
“Technology made large populations possible; large populations now make technology indispensable.”                – Joseph Krutch (Writer)Since the 19th century, we have undergone several stages of machine revolutions.The first stage was mechanisation. The advent of modern production methods eased and sped up manufacturing, massively increasing output and ushering in the Industrial Revolution.The late 60s brought the age of the working computer. In 1967, an IBM infomercial, ‘The Paperwork Explosion’, predicted a dystopi...
Source: EyeForPharma - June 22, 2017 Category: Pharmaceuticals Authors: Jacqui Sanders Source Type: news

Boston Scientific launches Alair asthma treatment in India
Boston Scientific (NYSE:BSX) has launched its Alair bronchial thermoplasty therapy in India, according to an India Blooms report. The device won clearance in the country with indications for treating severe, persistent, drug-resistant asthma in adult patients who’s asthma is not well controlled with inhaled corticosteroids and long acting beta antagonists. Marlborough, Mass.-based Boston Scientific’s Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. “There are over 18 million estimated a...
Source: Mass Device - June 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Respiratory Boston Scientific Source Type: news

Anika launches late-stage supplemental Cingal study
Anika Therapeutics (NSDQ:ANIK) said yesterday that it enrolled the 1st patient in a supplemental Phase III efficacy and safety trial of its Cingal hyaluronic acid-corticosteroid combination viscosupplement. The Bedford, Mass.-bsaed company is evaluating Cingal as a treatment for osteoarthritis-related knee pain. Get the full story at our sister site, Drug Delivery Business News. The post Anika launches late-stage supplemental Cingal study appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 26, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Orthopedics Pharmaceuticals Regenerative Medicine Wall Street Beat Anika Therapeutics Inc. Source Type: news

New medicine shows potential to reduce oral steroid use in severe asthma patients
(McMaster University) The results of the trial, published this week in the New England Journal of Medicine, demonstrate that patients treated with a potential new medicine and antibody, called benralizumab, were more than four times likely to reduce their usage of oral corticosteroids than those taking a placebo. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2017 Category: International Medicine & Public Health Source Type: news

Boston Scientific ’ s post-approval Alair study shows long-term asthma improvement
Patients treated with the Alair device made by Boston Scientific (NYSE:BSX) showed long-term improvement in controlling their asthma, according to a post-approval study released today at the annual meeting of the American Thoracic Society in Washington. The Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. Boston acquired the technology when it paid $194 million in cash for Asthmatx in 2010, shortly after that company won 510(k) clearance from the FDA for Alair. The deal also included some $250 million in pote...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Respiratory Wall Street Beat Boston Scientific Source Type: news